project id: TCGA-STAD; case submitter id: TCGA-R5-A7ZF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 7.9; age at index: 65; days to birth: -23908; days to death: 259; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1947; year of death: 2012; age at diagnosis: 23908; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 482; days to sample procurement: 0; initial weight: 5.0; sample id: aebfea6c-c91b-44f3-ac5e-4033f0cd3486; sample submitter id: TCGA-R5-A7ZF-01A; portion id: 689cd840-520d-4af7-b239-cfd86b8451d0; portion submitter id: TCGA-R5-A7ZF-01A-11; slide id: f08c5ec7-7292-4fd6-92ff-73192329c2b5; slide submitter id: TCGA-R5-A7ZF-01Z-00-DX1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 4.0; percent neutrophil infiltration: 10.0; percent normal cells: 1.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; section location: TOP;